市場調査レポート
商品コード
1624079

人間栄養向けプロバイオティクスの市場規模・シェア・成長分析 (種類別、用途別、地域別):産業予測 (2025~2032年)

Probiotics In Human Nutrition Market Size, Share, Growth Analysis, By Type (Lactobacillus, Bifidobacterium), By Application (Dietary Supplements, Functional Nutrition), By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 265 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
人間栄養向けプロバイオティクスの市場規模・シェア・成長分析 (種類別、用途別、地域別):産業予測 (2025~2032年)
出版日: 2025年01月01日
発行: SkyQuest
ページ情報: 英文 265 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の人間栄養向けプロバイオティクスの市場規模は、2023年に625億米ドルと評価され、予測期間 (2025-2032年) 中にCAGR 7.5%で成長し、2024年の671億9,000万米ドルから2032年には1,198億3,000万米ドルに成長する見通しです。

人間栄養向けプロバイオティクス市場は、CAGR 9.7%の堅調な伸びにより、2019年までに310万トンに達すると予測されます。予防医療が世界的に注目される中、天然由来プロバイオティクスに対する需要の急増がこの成長に大きく寄与しています。主要市場、特に中国、日本、インドでは、プロバイオティクスの生産が大きく発展しており、主要企業は効果的な菌株を開発するための研究に多額の投資を行っています。また、ヒト用と動物用のプロバイオティクスの送達デバイスの刷新も進んでおり、業界全体のトレンドになりつつあります。米国のような豊かな国では栄養補助食品の消費が増加しており、高齢化人口の増加と予防医療への関心の高まりが、プロバイオティクス栄養の需要を刺激し続けています。

目次

イントロダクション

  • 分析目的
  • 市場範囲
  • 定義

分析手法

  • 情報調達
  • 二次・一次データの手法
  • 市場規模予測
  • 市場の想定と制約

エグゼクティブサマリー

  • 市場の概要と展望
  • 需給動向の分析
  • セグメント別の機会分析

市場力学と展望

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーター分析

市場の主な考察

  • 主な成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場魅力度指数 (2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 価格分析
  • 規制分析
  • 特許分析

世界の人間栄養向けプロバイオティクスの市場規模・CAGR:種類別 (2025~2032年)

  • 市場概要
  • 乳酸菌
  • ビフィズス菌
  • サッカロミセス
  • 連鎖球菌
  • エンテロコッカス
  • 大腸菌
  • バチルス

世界の人間栄養向けプロバイオティクスの市場規模・CAGR:用途別 (2025~2032年)

  • 市場概要
  • 栄養補助食品
  • 機能性栄養
  • スポーツ栄養
  • 乳児の栄養
  • その他の用途

世界の人間栄養向けプロバイオティクスの市場規模・CAGR (2025~2032年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング (2024年)
  • 主要企業が採用した戦略
  • 市場の近年の動向
  • 主要企業の市場シェア (2024年)
  • 主要企業のプロファイル
    • 企業概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較 (2022~2024年)

主要企業のプロファイル

  • Danone S.A. (フランス)
  • Yakult Honsha Co., Ltd. (日本)
  • Nestle S.A. (スイス)
  • Chr. Hansen Holding A/S (デンマーク)
  • International Flavors & Fragrances Inc. (IFF) (米国)
  • Archer Daniels Midland Company (ADM) (米国)
  • Probi AB (スウェーデン)
  • BioGaia AB (スウェーデン)
  • Morinaga Milk Industry Co., Ltd. (日本)
  • Lifeway Foods, Inc. (米国)
  • General Mills, Inc. (米国)
  • PepsiCo, Inc. (米国)
  • Kerry Group plc (アイルランド)
  • Lallemand Inc. (カナダ)
  • UAS Laboratories LLC (米国)
  • Winclove Probiotics B.V. (オランダ)
  • DSM-Firmenich (オランダ/水s)
  • Sabinsa Corporation (米国)
  • Protexin (英国) (part of ADM)
  • Bifodan A/S (デンマーク)

結論と推奨事項

目次
Product Code: SQSG30I2045

Global Probiotics In Human Nutrition Market size was valued at USD 62.5 billion in 2023 and is poised to grow from USD 67.19 billion in 2024 to USD 119.83 billion by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).

The probiotics market within human nutrition is anticipated to reach an impressive 3.1 million tons by 2019, driven by a robust CAGR of 9.7%. The surge in demand for naturally-sourced probiotics is a major contributor to this growth, as preventative healthcare gains prominence globally. Key markets, particularly in China, Japan, and India, have seen significant advancements in probiotic production, with leading companies investing heavily in research to develop effective strains. Innovations in delivery devices for both human and animal probiotics are also emerging, set to trend throughout the industry. As affluent nations like the United States show rising consumption of dietary supplements, the increasing aging population and heightened focus on preventative healthcare continue to stimulate demand for probiotic nutrition.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Probiotics In Human Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Probiotics In Human Nutrition Market Segmental Analysis

Global Probiotics In Human Nutrition Market is segmented by Type, Application and region. Based on Type, the market is segmented into Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Enterococcus, Escherichia and Bacillus. Based on Application, the market is segmented into Dietary Supplements, Functional Nutrition,Sports Nutrition,Infant Nutritionand other applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Probiotics In Human Nutrition Market

The Global Probiotics in Human Nutrition market is experiencing significant growth driven by an increasing customer focus on health and wellness. As awareness of the importance of maintaining a healthy lifestyle rises, there is a growing demand for natural food products, particularly probiotics. Consumers are increasingly recognizing the multitude of health benefits associated with incorporating probiotics into their daily diets, such as enhanced gut health, improved immunity, better calcium absorption, and reduced calorie intake. This shift towards prioritizing personal well-being is propelling the market for probiotic ingredients, reflecting a broader trend of health-conscious consumption among individuals.

Restraints in the Global Probiotics In Human Nutrition Market

The Global Probiotics in Human Nutrition market faces significant constraints primarily due to the high research and development expenses associated with creating novel probiotic strains. These costs encompass investments in laboratories, advanced research equipment, and the employment of skilled personnel, all of which contribute to the financial burden on producers. The market's growth relies heavily on the scientific validation of probiotics' efficacy in various health-related applications. However, this dependence on research can make it challenging for manufacturers to achieve a satisfactory return on their substantial initial investments, potentially hindering overall market progress and innovation.

Market Trends of the Global Probiotics In Human Nutrition Market

The Global Probiotics in Human Nutrition market is witnessing a significant upward trend, driven by the increasing consumer awareness of gut health and the benefits of probiotics. In response, market participants are innovating their product lines, introducing a diverse array of probiotic supplements, such as capsules, pills, and drops, each featuring unique strains tailored to specific health needs. Additionally, both private label and branded producers are actively expanding their offerings, enhancing variety and accessibility for consumers. This trend reflects a robust market growth potential, as demand for probiotics continues to rise in conjunction with the broader health and wellness movement.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Analysis
  • Patent Analysis

Global Probiotics In Human Nutrition Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Lactobacillus
  • Bifidobacterium
  • Saccharomyces
  • Streptococcus
  • Enterococcus
  • Escherichia
  • Bacillus

Global Probiotics In Human Nutrition Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Dietary Supplements
  • Functional Nutrition
  • Sports Nutrition
  • Infant Nutrition
  • Other Applications

Global Probiotics In Human Nutrition Market Size & CAGR (2025-2032)

  • North America (Type, Application)
    • US
    • Canada
  • Europe (Type, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Danone S.A. (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Yakult Honsha Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nestle S.A. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chr. Hansen Holding A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • International Flavors & Fragrances Inc. (IFF) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Archer Daniels Midland Company (ADM) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Probi AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioGaia AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Morinaga Milk Industry Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lifeway Foods, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • General Mills, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PepsiCo, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kerry Group plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lallemand Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • UAS Laboratories LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Winclove Probiotics B.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DSM-Firmenich (Netherlands/Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sabinsa Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Protexin (UK) (part of ADM)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bifodan A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations